The US Food and Drug Administration has approved Eli Lilly’s Symbyax, a combination of...
|
The Food and Drug Administration is expected to approve Eli Lilly and Co.’s and Daiichi...
|
Eli Lilly and Co. has agreed to pay approximately $800 million for unapproved marketing and...
|
The findings of a new study add to the growing number of studies criticizing the class of newer...
|
The medical world is forever focusing on developing new treatments, medications and searching for...
|
The latest generation of antipsychotic drugs appears to be twice as likely to cause sudden...
|
Eli Lilly & Co. has announced on Wednesday that the Food and Drug Administration (FDA) is...
|
The US Food and Drug Administration refused to immediately approve a long-acting...
|
American researchers have identified 14 widely prescribed
drugs that are used for other conditions...
|
A Congressional investigation led by Sen.
Charles Grassley revealed in June that a world-renowned...
|
It appears that newer antipsychotics, such
as Zyprexa from Eli Lilly and Risperdal from Janssen...
|
New research by the National Institutes of Health’s National
Institute of Mental Health published...
|
The U.S. Food and Drug Administration on Monday warned
physicians that prescribing certain...
|
Anchorage, Alaska is the host of the first jury trial over the risks from Eli Lilly’s antipsychotic...
|
Eli Lilly and Company's schizophrenia drug, olanzapine (or, known for its brand name, Zyprexa,...
|
A new drug that addresses schizophrenia symptoms has shown considerably less side effects than the...
|
A new research conducted by Sudeep Gill, MD,
MSc, a geriatric medicine specialist, concluded that...
|
